Biogen (NASDAQ:BIIB) is soaring by about 45% this morning after saying it will move forward with filing for the approval on its Alzheimer drug aducanumab. The stock is blowing through all sorts of resistance levels this morning with, and a large gap fill that can take the stock back to $330. It is a big move for Biogen, which has been a dead stock for some time, and it is a big win for the biotech sector.
XBI biotech ETF is jumping this morning up by more than 1%. The ETF is challenging the downtrend and has the potential to rise to around $83.25.
Nvidia is getting closer to that big break out I noted in yesterday’s write-up, setting up the potential push towards $217.
SNAP is rising again today, and I, as noted yesterday in a premium story, the stock could rise to resistance at $15.50. If you had only signed up to read the article Bullish Bets Pile For SNAP Ahead Of Results22
Tesla (NASDAQ:TSLA) will report results tomorrow after the close of trading, and the stock has been moving higher since it reported delivery results. The company will need to post solid earnings and gross margins to see the stock move higher. If it can, the stock will make that move to $300 we have been talking about a couple of weeks.
Amazon (NASDAQ:AMZN) has been dead money since July, and the stock needs to get over $1850 before we can even talk about the stock rising any higher.
Add a Comment
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.